Earnings Summary

Abbvie Inc.’s revenue fell -4.92% since last year same period to $13865Mn in the Q2 2023. On a quarterly growth basis, Abbvie Inc. has generated 13.42% jump in its revenue since last 3-months.

Abbvie Inc.’s net profit jumped 119.05% since last year same period to $2024Mn in the Q2 2023. On a quarterly growth basis, Abbvie Inc. has generated 746.86% jump in its net profits since last 3-months.

Abbvie Inc.’s net profit margin jumped 130.39% since last year same period to 14.6% in the Q2 2023. On a quarterly growth basis, Abbvie Inc. has generated 646.69% jump in its net profit margins since last 3-months.

Abbvie Inc.’s earning per share (EPS) estimates for the current quarter stand at 3.68 - a 3.08% jump from last quarter’s estimates.

Abbvie Inc.’s earning per share (EPS) estimates for the current year stand at 3.68.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Abbvie Inc.’s return on assets (ROA) stands at 0.09.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Abbvie Inc.’s return on equity (ROE) stands at 0.63.

Abbvie Inc. declared 1.48 dividend per share during the earnings announcement for Q1 2023.